AI is no longer just a chip story — it’s showing up in retail, pharma, and healthcare services. The recent moves in $Wal-Mart(WMT)$ , $NVIDIA(NVDA)$ , $Eli Lilly(LLY)$ , and $Tempus AI(TEM)$ are not random.
1. What happened to this traditional giants and AI stars?
Walmart hit fresh highs as investors price in potential Nasdaq-100 inclusion and Google’s expansion of Gemini shopping. The upgrade turns Gemini from a recommendation assistant into a “virtual merchant” that can complete purchases, with Walmart among the retail partners.
At the same time, Nvidia and Eli Lilly announced a Bay Area joint research lab, with $1 billion committed over five years, using Nvidia’s Vera Rubin AI platform to support drug R&D.
Another datapoint comes from Tempus AI, which reported preliminary 2025 revenue of ~$1.27 billion, up ~83% YoY (~30% organic growth).
For the market, this is less about vision — and more about measurable commercialization.
Taken together, these moves point to one theme: AI is entering parts of the business that show up in revenue and margins.
output0.png
2. AI hardware remains a core 2026 theme
But investor focus is shifting. As compute supply expands, the question becomes: who can actually use AI to change how a business operates and earns money?
This helps explain why retail, pharma, and healthcare data companies are gaining attention.
3. Agentic workflows and where software value concentrates
Research on AI-driven, agentic workflows points to a longer-term shift: AI expands software TAM rather than destroying it.
However, value concentrates in layers that can:
Monetize compute
Orchestrate workflows across systems
Provide modern, neutral data foundations
At the infrastructure level, companies with reusable capital and diversified exposure, such as $Microsoft(MSFT)$ and $Oracle(ORCL)$ , are seen as structurally advantaged.
At the application level, competition is more fragmented. The key differentiators are platform speed and durable monetization. In this context, $ServiceNow(NOW)$ and $Snowflake(SNOW)$ stand out for governance, orchestration, and data integration.
The AI narrative is shifting — from owning compute to embedding AI into workflows that consistently generate returns.
Discussion:
If you could follow only one theme into 2026, which would it be, and why?
Can $Tempus AI(TEM)$ run further with surprising results?
Would $ServiceNow(NOW)$ & $Snowflake(SNOW)$ or $iShares Expanded Tech-Software Sector ETF(IGV)$ be your pick?
At what price would you add $NVIDIA(NVDA)$?
Leave your comments to win tiger coins!
Comments
AI is expected to drive above-trend earnings growth of 13-15% for the S&P 500 for at least the next two years.
Tempus AI ($TEM) has shown strong revenue growth, with Q3 2025 revenue up 84.7% year-over-year.
The company has also consistently beaten analyst consensus estimates for EPS and revenue in recent quarters. Just this week, the company announced strong preliminary 2025 results and strategic collaborations with entities like NYU Langone Health and Northwestern Medicine, which caused the stock to jump.
$NVIDIA Corp(NVDA)$ would probably consider around $173 [Thinking] [Thinking] [Thinking]
From Walmart $Wal-Mart(WMT)$ hitting new highs on the back of $Alphabet(GOOG)$ Google's Gemini "virtual merchant" upgrade to NVIDIA $NVIDIA(NVDA)$ and $Eli Lilly(LLY)$ Eli Lilly's partnership having a joint AI drug discovery lab, AI is being monetised to generate more revenue for companies.
The new AI Playbook is here in 2026! I would follow the money trail because this is where I can unearth great companies who are turning AI into a monetary rewards.
@Tiger_comments @TigerStars @TigerClub @Tiger_SG @CaptainTiger
如果执行力保持强劲,Tempus AI(TEM)仍有上涨空间。约83%的收入同比增长显示了真正的商业化,利润率或企业渗透率的任何改善都可能将该股重新评级为医疗保健基础设施,而不是纯粹的增长股。
在ServiceNow和Snowflake与IGV之间,我更喜欢平台。人工智能价值集中在编排和数据层,而不是广泛的软件篮子。对于英伟达,我仍然长期看涨,但只会增加情绪驱动的回调,而不是走强。
@TigerStars @TigerClub @Tiger_comments
ServiceNow (NOW) trades at a P/E ratio of over 83.61 with an average price target of $218.18, a forecasted upside of over 50%.
Snowflake (SNOW)is currently unprofitable (negative EPS) but has seen appreciation and trades in the middle of its 52-week range.(IGV) offers diversification, but its performance in 2025 lagged some broader indices and pure AI plays.